Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Gene Silencing/Gene Editing » Sirna Therapeutics and Archemix, Dharmacon and Genospectra, and Alnylam Pharmaceuticals

Sirna Therapeutics and Archemix, Dharmacon and Genospectra, and Alnylam Pharmaceuticals

Jul 30, 2004
Premium

Sirna to Manufacture Aptamers for Archemix, Posts Q2 Financials

Sirna Therapeutics said this week that it has signed an exclusive, four-year deal to manufacture all of Archemix’s aptamers used through phase IIa clinical development. Sirna has additionally granted a worldwide, non-exclusive, perpetual license to its aptamer manufacture and commercialization intellectual property to Archemix.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

More to Mix and Match

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

National Academy of Sciences May Expel Members

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

Nucleic Acids Research Papers on DNA-Bound Proteins, Transcriptional Activation, More

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

Pause Recommended

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

Apr
21
Featured Webinar

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

Sponsored by
Mission Bio

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies. 

Apr
23
Featured Webinar

Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity

Sponsored by
Isoplexis

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function. 

What's Popular?

In Gene Silencing/Gene Editing

  1. CRISPR-Cas9 Genome Editing Can Lead to Extensive Chromosome Rearrangements

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.